Details for New Drug Application (NDA): 021764

✉ Email this page to a colleague

NDA 021764 describes QOLIANA, which is a drug marketed by Sandoz and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the QOLIANA profile page.

The generic ingredient in QOLIANA is brimonidine tartrate. There are eleven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the brimonidine tartrate profile page.

Summary for 021764

Tradename:	QOLIANA
Applicant:	Sandoz
Ingredient:	brimonidine tartrate
Patents:	1

Pharmacology for NDA: 021764

Mechanism of Action	Adrenergic alpha-Agonists

Medical Subject Heading (MeSH) Categories for 021764

Adrenergic alpha-2 Receptor Agonists
Antihypertensive Agents

Suppliers and Packaging for NDA: 021764

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
QOLIANA	brimonidine tartrate	SOLUTION/DROPS;OPHTHALMIC	021764	NDA	Sandoz Inc	61314-144	61314-144-05	5 mL in 1 BOTTLE (61314-144-05)
QOLIANA	brimonidine tartrate	SOLUTION/DROPS;OPHTHALMIC	021764	NDA	Sandoz Inc	61314-144	61314-144-10	10 mL in 1 BOTTLE (61314-144-10)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SOLUTION/DROPS;OPHTHALMIC			Strength	0.15%
Approval Date:	May 22, 2006	TE:	AT	RLD:	Yes
Patent:	⤷ Get Started Free	Patent Expiration:	Aug 19, 2025	Product Flag?	Y	Substance Flag?		Delist Request?

Expired US Patents for NDA 021764

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Sandoz	QOLIANA	brimonidine tartrate	SOLUTION/DROPS;OPHTHALMIC	021764-001	May 22, 2006	⤷ Get Started Free	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.